A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants
Clinical trial NCT05988034 · COMPLETED
Trial details
- NCT number
- NCT05988034
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-08
- Primary completion
- 2020-01-22
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.